sorafenib has been researched along with Hyperkeratosis Palmaris et Plantaris in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lountzis, NI; Maroon, MS | 1 |
| Alter, M; Degen, A; Gutzmer, R; Kapp, A; Satzger, I; Schenck, F; Völker, B | 1 |
1 review(s) available for sorafenib and Hyperkeratosis Palmaris et Plantaris
| Article | Year |
|---|---|
The hand-foot-syndrome associated with medical tumor therapy - classification and management.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Dermatologic Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Eruptions; Foot Dermatoses; Hand Dermatoses; Humans; Keratoderma, Palmoplantar; Neoplasms; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Sorafenib | 2010 |
1 other study(ies) available for sorafenib and Hyperkeratosis Palmaris et Plantaris
| Article | Year |
|---|---|
Sorafenib-induced palmoplantar hyperkeratosis.
Topics: Antineoplastic Agents; Benzenesulfonates; Carcinoma, Renal Cell; Female; Humans; Keratoderma, Palmoplantar; Kidney Neoplasms; Middle Aged; Niacinamide; Phenylurea Compounds; Pyridines; Sorafenib | 2008 |